CVE-2024-1619

CVE-2024-1619 is a medium-severity vulnerability in Kaspersky Security with a CVSS 3.x base score of 6.1. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-74.

Key facts

Description

Kaspersky has fixed a security issue in the Kaspersky Security 8.0 for Linux Mail Server. The issue was that an attacker could potentially force an administrator to click on a malicious link to perform unauthorized actions.

Frequently asked questions

What is CVE-2024-1619?
Kaspersky has fixed a security issue in the Kaspersky Security 8.0 for Linux Mail Server. The issue was that an attacker could potentially force an administrator to click on a malicious link to perform unauthorized actions.
How severe is CVE-2024-1619?
CVE-2024-1619 has a CVSS 3.x base score of 6.1, rated medium severity. It is exploitable over network with low attack complexity, requires no privileges and user interaction. Impact on confidentiality is low, integrity low, and availability none.
Is CVE-2024-1619 being actively exploited?
It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (30th percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2024-1619?
CVE-2024-1619 affects Kaspersky Security. See the affected-products list for the exact vulnerable versions.
How do I fix CVE-2024-1619?
Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.
Does CVE-2024-1619 have an EU (EUVD) identifier?
Yes. CVE-2024-1619 is tracked in the ENISA EU Vulnerability Database (EUVD) as EUVD-2024-17359.
When was CVE-2024-1619 published?
CVE-2024-1619 was published on 2024-02-29 and last updated on 2026-06-17.

References

Affected products (1)

Other CWE-74 (Improper Neutralization of Special Elements (Injection)) vulnerabilities

Browse all CWE-74 (Improper Neutralization of Special Elements (Injection)) vulnerabilities →